Jump to content
Knowledge Hub

FDA - Q9(R1) Quality Risk Management (Draft Guidance Document)

30th August 2022

FDA - Q9(R!) QRM Draft Guidance

Risk management principles are effectively utilized in many areas of business and government including finance, insurance, occupational safety, public health, pharmacovigilance, and by agencies regulating these industries. In the pharmaceutical sector, the principles and framework of ICH Q9, coupled with the official ICH training material that supports this guideline, are instrumental in enhancing the application of effective quality risk management by industry and regulators. The importance of quality systems has been recognized in the pharmaceutical industry, and it is evident that quality risk management is a valuable component of an effective quality system.

Read more and submit comments here

Back to News Archive


Virtual Event Platform